30
SEP
Welcome To MJPPS
The editors welcome the submission of relevant articles for editorial consideration. Manuscripts should be addressed to
editor@medjpps.com
.
Mediterranean Journal of Pharmacy and Pharmaceutical Sciences
Mediterranean Journal of Pharmacy and Pharmaceutical Sciences
Home
About the Journal
Editorial Board
Guidelines and Policies
Current Edition
Archive
Contact
Search for an article:
With the Article Type:
All types
Case report
Commentary
Editorial
Opinion
Original article
Review
Short communication
review
With the Article Area:
All areas
Biochemistry
Clinica; Microbiology
Clinical Microbiology
Clinical Pharmacology
Clinical Pharmacy
Clinical biochemistry
Education
Healthcare
Medical Education
Medicinal Plant
Medicinal chemistry
Microbiology
Molecular Biology
Natural products
Pharmaceutical care
Pharmaceutical education
Pharmaceutics
Pharmacognosy
Pharmacology
Pharmacy
Pharmacy education
Pharmacy practice
Physiology, Pathology
Quality control
Toxicology
At Edition:
All editions
Volume 5, Issue 2
Volume 5, Issue 1
Volume 4, Issue 4
Volume 4, Issue 3
Volume 4, Issue 2
Volume 4, Issue 1
Volume 3, Issue 4
Volume 3, Issue 3
Volume 1, Issue 4
Volume 1, Issue 3
Volume 1, Issue 2
Volume 1, Issue 1
Volume 3, Issue 2
Volume 3, Issue 1
Volume 2, Issue 4
Volume 2, Issue 3
Volume 2, Issue 2
Volume 2, Issue 1
Ahead of Print
At Year:
All years
2025
2024
2023
2022
2021
Update Results
4
resultados para
Sanjay Sukumar Saralaya
https://doi.org/10.5281/zenodo.14645927
Mediterr J Pharm Pharm Sci, vol.5, March, 2025
A comprehensive analysis of disclosed synthetic strategies in prior arts from 2013-2024 (Part II) regarding the preparation of the renowned drug, Febuxostat, and its related scaffolds
Sanjay
Sukumar
Saralaya
Review
PDF
2025 - Vol. 5 / Issue 1
A comprehensive analysis of disclosed synthetic strategies in prior arts from 2013-2024 (Part II) regarding the preparation of the renowned drug, Febuxostat, and its related scaffolds
Sanjay
Sukumar
Saralaya
https://doi.org/10.5281/zenodo.14645885
Mediterr J Pharm Pharm Sci, vol.5, 01, March, 2025
A comprehensive analysis of disclosed synthetic strategies in prior arts from 1970-2012
(Part I) regarding synthesizing the renowned drug, Febuxostat, and its related compounds
Sanjay
Sukumar
Saralaya
Review
PDF
2025 - Vol. 5 / Issue 1
A comprehensive analysis of disclosed synthetic strategies in prior arts from 1970-2012
(Part I) regarding synthesizing the renowned drug, Febuxostat, and its related compounds
Sanjay
Sukumar
Saralaya
https://doi.org/10.5281/zenodo.10698581
Mediterr J Pharm Pharm Sci, vol.4, March, 2024
A collective review of the synthetic approaches disclosed in prior patents
to synthesize the renowned drug, Lamotrigine
Sanjay
Sukumar
Saralaya
, Shridhara Kanakamajalu, Shashikumar Somashekar Hiriyalu
Review
PDF
2024 - Vol. 4 / Issue 1
A collective review of the synthetic approaches disclosed in prior patents
to synthesize the renowned drug, Lamotrigine
Sanjay
Sukumar
Saralaya
, Shridhara Kanakamajalu, Shashikumar Somashekar Hiriyalu
https://doi.org/10.5281/zenodo.10208022
Mediterr J Pharm Pharm Sci, vol.3, December, 2023
A progressive review on the synthesis of Atovaquone (an anti-malarial drug), empowered by the critical examination of prior-art disclosures
Sanjay
Sukumar
Saralaya
, Shridhara Kanakamajalu
review
PDF
2023 - Vol. 3 / Issue 4
A progressive review on the synthesis of Atovaquone (an anti-malarial drug), empowered by the critical examination of prior-art disclosures
Sanjay
Sukumar
Saralaya
, Shridhara Kanakamajalu
Mediterr J Pharm Pharm Sci
Home
About the Journal
Editorial Board
Guidelines and Policies
Current Edition
Archive
Contact
author_index
Share this page
Google+
Facebook
Twitter
Email
Page Sections